SAM
CDTX

Sectoral Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Sectoral Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,272
Closed -$67K – 93
2019
Q1 		$67K Hold
1,272
– – 0.01% 103
2018
Q4 		$60K Hold
1,272
– – 0.01% 98
2018
Q3 		$112K Buy
+1,272
New +$112K 0.01% 157

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Sectoral Asset Management's CDTX Position: Q2 2019 in Review

Sectoral Asset Management sold out of Cidara Therapeutics (CDTX) in Q2 2019, closing a stake of 1,272 shares — an estimated $67K sold.

Sectoral Asset Management first reported a position in CDTX in Q3 2018 and held it in 3 quarters. The position peaked at $112K in Q3 2018. 45 funds tracked by Wall St. Rank hold CDTX as of Q2 2019.

  • Sectoral Asset Management reported no remaining Cidara Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Sectoral Asset Management sold 1,272 Cidara Therapeutics shares in Q2 2019, an estimated $67K.
  • Sectoral Asset Management first reported a position in Cidara Therapeutics in Q3 2018 and held it in 3 quarters.
  • Sectoral Asset Management's Cidara Therapeutics position peaked at $112K in Q3 2018.
  • 45 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2019.

Based on Sectoral Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.